[1] |
陈谦明 . 口腔黏膜病学[M]. 4版. 北京: 人民卫生出版社, 2012: 103-105.
|
|
Chen QM. Oral mucosal disease[M]. 4th ed. Beijing: People’s Medical Publishing House, 2012: 103-105.
|
[2] |
Alrashdan MS, Cirillo N , McCullough M. Oral lichen planus: a literature review and update[J]. Arch Dermatol Res, 2016,308(8):539-551.
doi: 10.1007/s00403-016-1667-2
URL
pmid: 27349424
|
[3] |
Tarasenko SV, Shatokhin AI, Umbetova KT , et al. T-cells immunity in oral lichen planus pathogenesis[J]. Stomatologiia (Mosk), 2014,93(1):60-63.
|
[4] |
Collison LW, Workman CJ, Kuo TT , et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function[J]. Nature, 2007,450(7169):566-569.
doi: 10.1038/nature06306
URL
pmid: 18033300
|
[5] |
Niedbala W, Wei XQ, Cai BL , et al. IL-35 is a novel cytokinewith therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells[J]. Eur J Immunol, 2007,37(11):3021-3029.
doi: 10.1002/eji.200737810
URL
pmid: 17874423
|
[6] |
Sawant DV, Hamilton K, Vignali DA . Interleukin-35: expanding its job profile[J]. J Interferon Cytokine Res, 2015,35(7):499-512.
doi: 10.1089/jir.2015.0015
URL
pmid: 25919641
|
[7] |
Collison LW, Delgoffe GM, Guy CS , et al. The composition and signaling of the IL-35 receptor are unconventional[J]. Nat Immunol, 2012,13(3):290-299.
doi: 10.1038/ni.2227
URL
|
[8] |
Vignali DA, Kuchroo VK . IL-12 family cytokines: immunological playmakers[J]. Nat Immunol, 2012,13(8):722-728.
doi: 10.1038/ni.2366
URL
|
[9] |
Floss DM, Schönberg M, Franke M , et al. IL-6/IL-12 cytokine receptor shuffling of Extra-and intracellular domains reveals canonical STAT activation via synthetic IL-35 and IL-39 signaling[J]. Sci Rep, 2017,7(1):15172.
doi: 10.1038/s41598-017-15173-3
URL
pmid: 29123149
|
[10] |
Behzadi P, Behzadi E, Ranjbar R . IL-12 family cytokines: general characteristics, pathogenic microorganisms, receptors, and signalling pathways[J]. Acta Microbiol Immunol Hung, 2016,63(1):1-25.
doi: 10.1556/030.63.2016.1.1
URL
pmid: 27020866
|
[11] |
王荣, 刘芳, 江南 , 等. 口腔扁平苔藓病损组织中白细胞介素35的表达及意义[J]. 中华口腔医学杂志, 2018,53(1):13-19.
|
|
Wang R, Liu F, Jiang N , et al. Expression and significance of interleukin-35 in lesion tissue of oral lichen planus patients[J]. Chin J Stomatol, 2018,53(1):13-19.
|
[12] |
Schmittgen TD, Livak KJ . Analyzing real-time PCR data by the comparative C(T) method[J]. Nat Protoc, 2008,3(6):1101-1108.
doi: 10.1038/nprot.2008.73
URL
pmid: 18546601
|
[13] |
Fu HY, Li C, Yang W , et al. FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape[J]. Acta Histochem, 2013,115(2):151-157.
doi: 10.1016/j.acthis.2012.06.002
URL
pmid: 22749378
|
[14] |
贾沛茹, 刘芳, 柳汀 , 等. 口腔扁平苔藓病损中Th17/Treg平衡及意义[J]. 实用口腔医学杂志, 2018,34(5):39-43.
|
|
Jia PR, Liu F, Liu T , et al. Th17/Treg balance in local lesions of oral lichen planus[J]. J Pract Stomatol, 2018,34(5):39-43.
|
[15] |
刘芳, 蔡扬 . 白细胞介素-35及其与口腔疾病的关系[J]. 国际口腔医学杂志, 2018,45(6):716-722.
|
|
Liu F, Cai Y . Interleukin-35 and its relationship with oral diseases[J]. Int J Stomatol, 2018,45(6):716-722.
|
[16] |
Collison LW, Chaturvedi V, Henderson AL , et al. IL-35-mediated induction of a potent regulatory T cell population[J]. Nat Immunol, 2010,11(12):1093-1101.
doi: 10.1038/ni.1952
URL
pmid: 20953201
|
[17] |
Zhang JF, Zhang YS, Wang QP , et al. Interleukin-35 in immune-related diseases: protection or destruction[J]. Immunology, 2019,157(1):13-20.
doi: 10.1111/imm.13044
URL
pmid: 30681737
|
[18] |
Hao SN, Chen X, Wang F , et al. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells[J]. Carcinogenesis, 2018,39(12):1488-1496.
doi: 10.1093/carcin/bgy136
URL
pmid: 30321288
|
[19] |
Guo YF, Cao W, Zhu Y . Immunoregulatory functions of the IL-12 family of cytokines in antiviral systems[J]. Viruses, 2019,11(9):E772.
doi: 10.3390/v11090772
URL
pmid: 31443406
|
[20] |
Stark GR, Darnell JE Jr . The JAK-STAT pathway at twenty[J]. Immunity, 2012,36(4):503-514.
doi: 10.1016/j.immuni.2012.03.013
URL
|